journal
https://read.qxmd.com/read/38452287/readiness-and-personality-disorders-considering-patients-readiness-for-change-and-our-system-s-readiness-for-patients
#1
JOURNAL ARTICLE
Connor Hawkins, David Kealy
The culture around personality disorder treatment has changed drastically in the past generation. While once perceived as effectively untreatable, there are now numerous evidence-based treatment approaches for personality disorders (especially borderline personality disorder). The questions, however, of who should be matched to which treatment approach, and when, remain largely unanswered. In other areas of psychiatry, particularly substance use disorders and eating disorders, assessing patient treatment readiness is viewed as indispensable for treatment planning...
March 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38452286/psychotherapy-in-the-digital-era-a-case-for-hybrid-care-and-remote-therapeutic-monitoring
#2
JOURNAL ARTICLE
George Luke Hartstein, Pamela Peck, Peter Yellowlees, John Torous
No abstract text is available yet for this article.
March 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38452285/the-role-of-psychiatry-for-transgender-and-gender-diverse-adults
#3
REVIEW
Maggie Beazer, Micah Breiger, Alex S Keuroghlian
Since the inclusion of gender identity disorder in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), psychiatry and the broader medical field have made substantial alterations in their recognition of and respect for transgender and gender diverse (TGD) identities. As this recognition continues to expand, psychiatrists should be aware of both historical harm and current best care practices, especially in light of psychiatric morbidity in TGD populations relative to the general population...
March 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38452284/assessment-and-treatment-of-abnormal-involuntary-movements-a-clinically-focused-narrative-review
#4
REVIEW
Aldis Petriceks, Chirag M Vyas, Shreedhar Paudel, Abigail L Donovan, Manjola U Van Alphen, Theodore A Stern
LEARNING OBJECTIVES: After participating in this CME activity, the psychiatrist should be better able to:• Categorize and describe different types of abnormal involuntary movements (AIMs).• Identify assessment tools and treatment options for AIMs. ABSTRACT: Abnormal involuntary movements (AIMs) comprise a diverse group of movement disorders characterized by uncontrolled and unintended movements (e.g., tremors, tics, dystonia). AIMs can occur at any stage of life and pose significant challenges for clinicians...
March 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38181102/the-tarnished-legacy-of-a-wonder-drug-revisiting-the-complicated-history-of-clozapine
#5
JOURNAL ARTICLE
Roshan Poudel, Barron Lerner
Anecdotal evidence of superior efficacy and lack of extrapyramidal symptoms in treating schizophrenia made clozapine a promising therapy in the United States during the early 1970s. In 1975, however, numerous fatal cases of clozapine-related agranulocytosis in Finland nearly ended the drug's development. Convinced of the significant benefits to patients, some clinicians in the United States advocated having clozapine available on a case-by-case humanitarian basis, which eventually helped resurrect the drug for Food and Drug Administration approval in 1989...
January 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38181101/diagnosis-and-management-of-perimenstrual-cycloid-motility-psychosis
#6
JOURNAL ARTICLE
Michelle Weyhaupt, Savanah Hardcastle, Nicholas Jesse, Marcela Almeida, Heather Burrell Ward
No abstract text is available yet for this article.
January 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38181100/on-the-classification-and-reporting-of-prolonged-grief-assessment-and-research-guidelines
#7
REVIEW
Margaret S Stroebe, Henk A W Schut, Maarten C Eisma
LEARNING OBJECTIVES AFTER PARTICIPATING IN THIS CME ACTIVITY, THE PSYCHIATRIST SHOULD BE BETTER ABLE TO: • Explain the steps required for diagnosis of mental disorders in diagnostic handbooks.• Identify current procedures for classifying and reporting prolonged grief disorder. ABSTRACT: Prolonged grief disorder (PGD) was added to the 11th edition of the International Classification of Diseases in 2018 and to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders in its 2022 text revision...
January 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/38181099/the-diagnostic-spectrum-of-sexual-hallucinations
#8
JOURNAL ARTICLE
Jan Dirk Blom, Rosemarij J B van Veen, Emma H C van Rooijen, Christina W Slotema
Sexual hallucinations are little known, yet often extremely burdening, phenomena. In this systematic review, we summarize what is known about their phenomenology, prevalence, etiopathology, ensuing distress, and treatment options. Sexual hallucinations can be experienced as genital or orgasmic sensations, although other sensory modalities can also be involved. With the notable exception of orgasmic auras in the context of epilepsy, sexual hallucinations tend to be distressing and embarrassing in nature. Our analysis of 79 studies (together describing 390 patients) indicates that sexual hallucinations are more frequent in women than in men, with a sex ratio of 1...
January 2024: Harvard Review of Psychiatry
https://read.qxmd.com/read/37948155/exploring-a-multidisciplinary-approach-to-wernicke-s-encephalopathy-in-pregnancy
#9
JOURNAL ARTICLE
Rachel Belfer, Alexandra Fields, Rafael Gonzalez-Alonso, Carolyn Sargent, Rubiahna L Vaughn, Aviva Caroff, Eric J Mariuma, Ketevan Amirkhanashvili, Runjhun Bhatia, Andrea Murez
No abstract text is available yet for this article.
November 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37948154/toward-a-psychological-model-of-chemical-coping-with-opioids-in-cancer-care
#10
JOURNAL ARTICLE
Miryam Yusufov, William F Pirl, Ilana M Braun, Timothy Sannes, R Kathryn McHugh
LEARNING OBJECTIVES AFTER PARTICIPATING IN THIS CME ACTIVITY, THE PSYCHIATRIST SHOULD BE BETTER ABLE TO: • Outline the risk factors involved with opioid accessibility in patients receiving treatment for cancer.• Identify factors to address in order to mitigate risk for opioid misuse during cancer care. ABSTRACT: Most patients with advanced cancer receive treatment for related pain. Opioid accessibility, however, is a risk factor for misuse, which can present care challenges and quality-of-life concerns...
November 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37870219/mental-health-is-heart-health-adjusting-clinical-guidelines-for-depression-after-myocardial-infarction
#11
JOURNAL ARTICLE
Christian R Hardoy, Jonathan H Shipley, Eric N Kramer, Robert M McCarron
No abstract text is available yet for this article.
November 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37823781/hero-or-antagonist-a-case-series-on-the-tolerability-of-memantine-as-salvage-therapy-for-catatonia-from-anti-nmda-receptor-encephalitis
#12
JOURNAL ARTICLE
Jennifer Wang, Samir J Abu-Hamad, Michael Jennings, Kyle Blackburn, Diana M Robinson
No abstract text is available yet for this article.
October 13, 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37823777/use-of-first-generation-antipsychotics-in-an-adolescent-male-with-catatonic-schizophrenia
#13
JOURNAL ARTICLE
Emmy Masur Patterson, Jacqueline Lim, Paul Fuchs, Joshua R Smith, Alexandra Moussa-Tooks, Heather Burrell Ward
No abstract text is available yet for this article.
October 13, 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37699068/psychopharmacological-considerations-for-gender-affirming-hormone-therapy-erratum
#14
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37699067/a-case-of-functional-cognitive-disorder-psychotherapy-and-speech-and-language-therapy-insights
#15
JOURNAL ARTICLE
Ellen J Godena, Jennifer L Freeburn, Noah D Silverberg, David L Perez
No abstract text is available yet for this article.
September 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37699066/potential-role-of-smartphone-technology-in-advancing-work-on-neurological-soft-signs-with-a-focus-on-schizophrenia
#16
JOURNAL ARTICLE
Lucy E Gray, Robert W Buchanan, Matcheri S Keshavan, John Torous
LEARNING OBJECTIVE AFTER PARTICIPATING IN THIS CME ACTIVITY, THE PSYCHIATRIST SHOULD BE BETTER ABLE TO: • Outline and Identify potential benefits of using neurological soft signs (NSS) as biomarkers of schizophrenia. ABSTRACT: Since the late 1960s, NSS have been a focus of study across psychiatric illnesses, including depression, bipolar disorder, and schizophrenia in particular. Utilizing these subtle neurological impairments as biomarkers of illness has numerous benefits; NSS offer a direct connection between clinical presentation and neurological functioning, and assessments are cost-effective...
September 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37615524/a-grave-set-of-diagnoses-a-case-of-mania-with-comorbid-autoimmune-thyroiditis-precipitated-by-multiple-sclerosis-treatment
#17
JOURNAL ARTICLE
Han Yue, Sejal B Shah, Katherine L Modzelewski, Mark Knobel, Frank Copeli, Larkin Kao
No abstract text is available yet for this article.
August 23, 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37504826/beyond-epistemic-injustice-when-perceived-realities-conflict
#18
JOURNAL ARTICLE
Rajvinder Samra
No abstract text is available yet for this article.
July 28, 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37504796/a-23-year-old-woman-with-psychotic-mania-and-a-report-of-sexual-violence-during-a-psychiatric-hospitalization
#19
JOURNAL ARTICLE
Kati N Lake, Victoria M Wilkins, Elizabeth B Ford, Sharon J Parish, Reile M Slattery, Mark J Russ, Benjamin D Brody
No abstract text is available yet for this article.
July 28, 2023: Harvard Review of Psychiatry
https://read.qxmd.com/read/37437254/sodium-glucose-cotransporter-2-inhibitors-in-depression
#20
JOURNAL ARTICLE
David T Liebers, Wataru Ebina, Dan V Iosifescu
Novel treatment strategies that refract existing treatment algorithms for depressive disorders are being sought. Abnormal brain bioenergetic metabolism may represent an alternative, therapeutically targetable neurobiological basis for depression. A growing body of research points to endogenous ketones as candidate neuroprotective metabolites with the potential to enhance brain bioenergetics and improve mood. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, originally approved for the treatment of diabetes, induce ketogenesis and are associated with mood improvement in population-based studies...
July 2023: Harvard Review of Psychiatry
journal
journal
31434
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.